NVR ABL Pill - red & yellow capsule/oblong, 12mm
Generic Name: nilotinib
Pill with imprint NVR ABL is Red & Yellow, Capsule/Oblong and has been identified as Tasigna 50 mg.
Tasigna is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR ABL
Tasigna
- Generic Name
- nilotinib
- Imprint
- NVR ABL
- Strength
- 50 mg
- Color
- Red & Yellow
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0951
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
lactose monohydrate,
magnesium stearate,
poloxamer 188,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide
Note: Inactive ingredients may vary.
More about Tasigna (nilotinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
